Delivery Order W81XWH18D0027-W81XWH19F0041

This is a federal contract award to Aapharmasyn LLC, a small disadvantaged business, for Experimental Therapeutics Medicinal Chemistry services. The contract was awarded by the Defense Health Agency, a component of the U.S. Department of Defense, with a ceiling value of $77,780.00. The contract has a firm fixed price pricing type and was awarded as a delivery order under the Experimental Therapeutics Medicinal Chemistry contract vehicle. The contract does not have a set-aside designation. The...

Medchemexpress LLC was awarded a firm fixed price purchase order valued at seventy-seven thousand one hundred ninety-three dollars and forty-one cents ($77,193.41) by the Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse to deliver one chemical library of five hundred nine bioactive compounds. The award originated from a sources sought notice issued by the National Institutes of Health's National Center for Advancing Translational...

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Medchemexpress LLC, a foreign-owned, minority-owned, self-certified small disadvantaged business. The $10,700 contract is for the provision of commercial chemical and drug reagents, with a period of performance ending on July 28, 2026. Medchemexpress is a New Jersey-based company that specializes in supplying chemical compounds, research materials, and scientific synthesis...

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $2.1 million firm fixed price purchase order to Avista Pharma Solutions, Inc., doing business as Cambrex, for the acquisition of two kilograms of cGMP-grade GS-441524 drug substance with an option for two additional kilograms. The drug substance will support preclinical and Phase I clinical studies by the NIH to evaluate GS-441524's potential as a COVID-19 treatment through assessing its safety,...

Organix Chemistry Solutions LLC was awarded a $3.677 million delivery order against the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences' CRO Support for NCATS Medicinal Chemistry for Lead Optimization master IDIQ contract. The delivery order, issued for the period of September 28, 2020 through September 27, 2022, provides synthetic chemistry support services to the TDB Medicinal Chemistry Team. Key services will involve...

The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) awarded a $30,035 firm fixed price purchase order to Medchemexpress LLC of Princeton, New Jersey for the synthesis of synthetic compounds to support NCATS. Under the terms of the award, Medchemexpress will provide synthetic compound synthesis services to NCATS by November 11, 2022. No set-aside provisions were applied to this procurement. As the lead institute for NIH's translational...

This contract award to Gempharmatech LLC, a foreign-owned biotechnology company in San Diego, California, is for a $58,936 fixed-price purchase order to evaluate the safety of the compound YC1 in mice with humanized SULT1A1 proteins versus standard mouse SULT1A1 proteins. The contract was awarded by the National Center for Advancing Translational Sciences (NCATS), which operates under the National Institutes of Health within the Department of Health and Human Services. The objective is to...

This is a $2,332,902 cost-plus-fixed-fee delivery order awarded by the National Cancer Institute (NCI) to Alchem Laboratories Corporation, a for-profit manufacturer based in Florida. The contract is for the synthesis of non-GMP (non-Good Manufacturing Practice) small molecule samples to support the NCI's research. Alchem Laboratories has multiple federal indefinite delivery vehicle (IDV) contracts with the NCI and National Institute of Allergy and Infectious Diseases (NIAID) for preclinical...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $827,789 firm fixed price delivery order against its CRO Support for NCATS Drug Substance Development and Manufacture master IDIQ contract to Bachem Americas, Inc. to support the manufacture of 1 kg of CGMP L-ENK in support of the Center's drug substance development and manufacture program. Performance will take place in Torrance, California over a four-year...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $581,604 firm fixed price purchase order to Avista Pharma Solutions, Inc., doing business as Cambrex, to acquire approximately 2-3 kilograms of cGMP-grade GS-441524 for potential treatment of COVID-19. The award is pursuant to a combined synopsis/solicitation seeking this same cGMP material from Avista, as they are currently producing non-cGMP GS-441524 under...